Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000059069 | SCV000281293 | benign | not provided | 2015-10-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000059069 | SCV001150543 | likely benign | not provided | 2018-05-01 | criteria provided, single submitter | clinical testing | |
Uni |
RCV000059069 | SCV000090590 | not provided | not provided | no assertion provided | not provided | ||
OMIM | RCV001172482 | SCV001335512 | pathogenic | Immunodeficiency 33 | 2024-07-18 | no assertion criteria provided | literature only | |
Pediatric Infectious Diseases and Immunodeficiencies Unit |
RCV003493432 | SCV004023254 | uncertain significance | Common variable immunodeficiency | no assertion criteria provided | clinical testing | We found the IKBKG c.169G>A / p.Glu57Lys variant in an adult female patient with common variable immunodeficiency (CVID). The variant has a very low frequency in the reference population databases (gnomad v3.1.2 MAF:0.001). The patient had skewed X chromosome inactivation, causing predominant expression of the mutated allele. Different studies reported functional alterations of the nuclear factor-κB (NF-κB) pathway: Gautheron et al showed that p.Glu57Lys variant is associated with a defect in TRAF6-dependent signaling pathways (i.e. IL-1 beta signaling) (PMID: 20529958). Frans et al showed a decrease of IL6 induction upon stimulation with IL-1 beta and TNF-alpha in SV40-transformed NEMO -/- fibroblasts transduced with p.Glu57Lys NEMO (PMID: 28993958). The IKBKG p.Glu57Lys variant has been reported in female patients with mild forms of incontinentia pigmenti (IP) and in a male patient with immunodeficiency (including hypogammaglobulinemia) but without ectodermal dysplasia (PMIDs: 15229184, 20529958, 28993958). The p.Glu57Lys variant has also been identified in healthy individuals (both males and females), consistent with its relatively high allele frequency. Therefore, we consider it a Variant of Uncertain Significance | |
Prevention |
RCV003905029 | SCV004718961 | likely benign | IKBKG-related disorder | 2023-09-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |